Switch to Advanced for indicator panels, raw grades, provenance, drawing tools, and full technical tables.
$MRK
Merck & Company, Inc.
Merck & Company, Inc. is
a mega-cap
Pharmaceuticals: Major company in the Health Technology sector with a market cap of
$347B.
Health TechnologyPharmaceuticals: MajorstockStage 2 · AdvancingBase 1Scan vol↑ 1.8×
$140.61latest close
⚠ Risk Signals
Double TopDouble Top (forming): peaks $152.80 and $152.34 (2026-10-15) with the neckline at $138.80. neckline $138.80 intact (1.3% above it). Measured move targets $125.03; invalidation above $155.86. Research/educational only, not a buy/sell recommendation.
Bearish structure on the daily chart — a heads-up for anyone holding, not a short signal. Does not affect the bullish setup score.
Market Structure
Trend structure:downtrend
Latest event:structure_shift(bullish)
Support
122.19–123.46
· 6 touches · strong
Support
113.82–114.62
· 4 touches · moderate
Support
106.93–107.59
· 3 touches · moderate
Support
110.94–111.57
· 3 touches · moderate
Momentum Turn Watch
Bollinger Squeeze + Lower-Band SupportBollinger band width (7.7%) is in the bottom quartile of its last 120 sessions — Legend's width-percentile squeeze (not a TTM/Keltner squeeze), so volatility is compressed and a sharper move often follows. Price ($140.61) is holding just above the lower Bollinger band ($139.22; %B 12) — support at the bottom of the bands.
Early technical context only. Wait for price, volume, and the canonical setup trigger to confirm; this signal does not change readiness or the setup score.
Triggers when price crosses your target during market hours or after the next daily scan. Delivered via email and Telegram (if linked in Account).
Historical record
No active setup in the latest scan — this page shows the last detection Legend AI made for $MRK.
Every level, score and criterion below is computed from the Oct 26 close session (latest session), and may no longer hold.
Historical verdict · setup score 86/100 · data Oct 26 close · latest session
Stand aside — setup invalidated
Setup score 86, but distribution days reach 5 or more — stand aside until the condition resets.
Weinstein: watchStage-analysis read: Stage 2 is present; 1 supporting checks need improvement.
66Strong
Legend Score · rates the stockStrong (66/100) — held back by eps growth
Our proprietary 0-100 rating — the answer to Wall Street's black-box scores. Five pillars, each computed from real scan data, each explained below in plain English.
Relative Strength (25%)90
Trend Template (25%)100
Institutional Footprint (20%)38
EPS Growth (15%)29
Quality (SMR-like) (15%)44
RS rank 89: beating most of the market. Trend template 8/8: price above rising 50/150/200-day lines — textbook uptrend structure. Institutional score 38: mild distribution — sellers active. EPS -2% last quarter — no earnings momentum. Quality 44: weak fundamentals (sales growth 30, return on equity 41, leverage 100).
Updated 2026-10-23.
Earnings
Pre-earnings setup
Next earnings
Thursday, October 29, 2026Before market open
Exact clock time not supplied by source
Ordinary position sizing suppressed.
Earnings are less than three full trading sessions away; treat the gap as event risk, not ordinary stop-distance risk.
Deterministic evidence
MRK-3.21%
Sector proxy · XLV+0.00%
Broad market · SPY+0.71%
Same completed session window ending 2026-10-26.
MRK was -3.21 points vs XLV.
-3.92 points vs SPY.
QQQ, SMH moved against the stock — no index confirmation.
A sourced earnings report is still pending inside the risk window; ordinary technical conviction is reduced until it is out.
Price bars, sourced event fields, and benchmark math only. This can adjust displayed short-term conviction; it does not change the stored scanner score or readiness.
Generic technical analysis generated mechanically from price & volume — educational research only, not financial advice or a personalized recommendation. Levels are illustrative; confirm on your own chart. New to these terms? →
Legend Verdicts6 methodology checks
Who would consider this setup, why it qualifies, and what blocks it — calculated from the same deterministic methodology rules used across Legend AI. How to read the numbers: the setup score (86/100, in the verdict band) rates this trade setup. Each legend's A–D grade rates the same setup against that legend's own checklist — so a high score next to a C grade is not a contradiction. The setup can be strong without fitting that legend's style. When the council disagrees, the verdict band breaks the tie.
Council consensus:
6 of 9 legends are Watching — building, not yet a confirmed buy.
WeinsteinWatchBStage-analysis read: Stage 2 is present; 1 supporting checks need improvement.
mediumClassic Stage 2 advancing phase — strong weekly trend confirms uptrend. This is Weinstein's sweet spot: buy and hold while price remains above the 30-week MA.
dennisWatchBTurtle read: no Donchian signal. The system stays flat until price takes out the 20-day high.
Passing evidence
✓No breakdown below the 20-day channel20-day low $138.80
✓Volatility-unit sizing (1N ≈ 1% of equity)1N = $4.27 (3.03% of price); the Turtles size 1 unit so a 1N move ≈ 1% of equity, making the 2N stop ≈ 2% equity risk
zangerAvoidCZanger read: a hard gate is broken — either the pattern is not one of his six, or the entry is more than 5% past the breakout. He would not touch this.
Passing evidence
✓Not extended (≤5% above the breakout point)Measured as passing
✓Partial-profit plan: sell 20-30% at +15-20%Scale 20-30% at $161.70-$168.73; trail the rest
Failing evidence
✕Named Zanger pattern onlyPartial Move is not one of Zanger's six
zweigWatchDZweig read: part of his screen passes but not all: EPS growth above the market (≥15% QoQ); Insider buying — wait for the full growth screen before treating this as a Zweig setup.
Passing evidence
✓Reasonable price for the growth (P/E ≤ 35)Trailing P/E 19.3x — no PEG or forward P/E stored
No active breakout tracked — Legend AI monitors daily for pivot-point breaks.
What's a breakout?
Latest candle: Bearish Engulfing — Today's down candle engulfs yesterday's up candle — a bearish reversal warning, most significant after an extended advance.
Fundamentals & leadership quality — Minervini’s published criteria · 5/7 met
B
5/7 criteria
Separate score from the Minervini Trend Template (7/8): the Trend Template grades the price structure, this grades the company & leadership (earnings, sales, margins, RS rank). A stock can ride a clean trend while its fundamentals lag, so the two often differ by design — they are not the same checklist.
Livermore B · Watch — The deterministic methodology check is Watch; wait for the failing or incomplete criteria to improve before the trigger can qualify.
Pivot
Pro level
Published-method rule: Treat the resistance break as a pivotal point only while the primary trend and relative strength remain aligned. Evidence: Canonical setup geometry is available with Pro.
Entry trigger
Pro level
Published-method rule: Wait for price and volume to confirm the pivotal-point break; anticipation below the line is not confirmation. Evidence: Canonical setup geometry is available with Pro.
Initial stop
Pro level
Published-method rule: Place the initial stop below the pivotal line or the reaction low that would prove the breakout false. Evidence: Canonical setup geometry is available with Pro.
Trail
Rule-based
Published-method rule: Raise protection beneath successive higher reaction lows as the trend advances; never move a protective line farther away. Evidence: Planned management rule; no stored stop or broker order is changed automatically.
Exit / invalidation
Pro level
Published-method rule: Exit when price fails the pivotal line, breaks the latest meaningful reaction low, or shows abnormal reversal action. Evidence: Canonical setup geometry is available with Pro.
Deterministic educational plan, not a recommendation. No order or stop is changed automatically. Method and sources →
Possible head & shoulders top — not confirmed. Watch for a daily close below ~126.22 (neckline) to confirm, with measured-move risk toward ~95.52. A push back above 153.57 weakens the pattern; reclaiming 156.92 invalidates it.
Confirms below126.22
Invalidates at156.92
Left Shoulder135.05
Head156.92
Right Shoulder153.57
Neckline126.22
Target95.52
LS 135.05 / head 156.92 / RS 153.57, neckline ~126.22, vol_fading=yes
Predictive pattern recognition is educational — most forming structures never confirm. Wait for the confirmation level before treating this as a setup.
Grades the price structure — moving-average stacking, distance from the 52-week high/low, and relative strength above the ≥70 uptrend bar. This is the technical trend check; the company's fundamentals and ≥80 RS leadership are scored separately in the Grade Card.
✓
Price above SMA 150 & 200$140.61 vs SMA150 $129.43 / SMA200 $126.01
✓
SMA 150 above SMA 200SMA150 $129.43 vs SMA200 $126.01
✓
SMA 200 trending upSlope +4.08 over 20 days
✓
SMA 50 above SMA 150 & 200SMA50 $146.74
✗
Price above SMA 50$140.61 vs SMA50 $146.74
✓
30%+ above 52-week low+71.5% from $82.01
✓
Within 25% of 52-week high-10.4% from $156.92
✓
RS score above 70RS 89
Fundamentals
52W Range
78%
Mkt Cap SEC
346.9B
EPS QoQ
-161%
Rev YoY
+1%
ROE
18%
Gross Margin
78%
D/E
0.94
EPS TTM
$7.28
P/E TTM
19.3x
Float
2.5B
Insider
No Buy
Company
Company profile
Merck & Company, Inc.
MRK · NYSE
· Health Technology
· Pharmaceuticals: Major